Published in J Bioenerg Biomembr on February 01, 2007
3-Bromopyruvate: targets and outcomes. J Bioenerg Biomembr (2012) 1.27
Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc Natl Acad Sci U S A (2012) 1.27
Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta (2009) 1.26
Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene (2008) 1.21
Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion (2010) 0.94
Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis (2011) 0.92
Identification of an annonaceous acetogenin mimetic, AA005, as an AMPK activator and autophagy inducer in colon cancer cells. PLoS One (2012) 0.91
Mitochondrial complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death. Int J Cell Biol (2013) 0.90
Cluvenone induces apoptosis via a direct target in mitochondria: a possible mechanism to circumvent chemo-resistance? Invest New Drugs (2011) 0.87
Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PLoS One (2013) 0.84
Subcellular localization and activity of gambogic acid. Chembiochem (2012) 0.83
Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells. J Cancer Res Clin Oncol (2010) 0.81
Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer. Oncotarget (2015) 0.80
α-Tocopheryl succinate-based amphiphilic block copolymers obtained by RAFT and their nanoparticles for the treatment of cancer. Polym Chem (2015) 0.80
Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death. Pharmaceuticals (Basel) (2015) 0.79
Use of anti-cancer drugs, mitocans, to enhance the immune responses against tumors. Curr Pharm Biotechnol (2013) 0.78
Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer? BMC Cancer (2010) 0.78
Mitochondrial DNA aberrations and pathophysiological implications in hematopoietic diseases, chronic inflammatory diseases, and cancers. Ann Lab Med (2014) 0.77
Enhanced Bioactivity of α-Tocopheryl Succinate Based Block Copolymer Nanoparticles by Reduced Hydrophobicity. Macromol Biosci (2016) 0.76
Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5. ChemMedChem (2017) 0.75
Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide. J Mater Sci Mater Med (2017) 0.75
The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer (2002) 14.94
Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol (1997) 9.18
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev (2005) 8.95
Glycolysis inhibition for anticancer treatment. Oncogene (2006) 6.55
Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol (2005) 5.25
Mitochondria: releasing power for life and unleashing the machineries of death. Cell (2003) 5.07
Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ (2000) 4.34
Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell (2006) 3.97
Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem (2001) 3.95
Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer (2005) 3.85
Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res (2005) 3.79
Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A (2002) 3.57
Crystal structure of mitochondrial respiratory membrane protein complex II. Cell (2005) 3.44
Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem (2006) 3.31
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem (2004) 3.14
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem (2000) 3.12
Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci (2000) 3.04
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol (2001) 3.03
Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem (1996) 2.79
Apoptosis-based therapies for hematologic malignancies. Blood (2005) 2.77
Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ (2006) 2.56
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun (2004) 2.29
Redox regulation of transcriptional activators. Free Radic Biol Med (1996) 2.23
Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol Cell Biol (1998) 2.05
Injected cytochrome c induces apoptosis. Nature (1998) 2.05
PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem (2006) 2.02
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res (2002) 2.00
Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene (2006) 1.83
Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem (2006) 1.81
A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res (2005) 1.69
BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev (2005) 1.55
Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc Natl Acad Sci U S A (1998) 1.49
Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL. J Am Chem Soc (2005) 1.46
Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J (2001) 1.33
Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J (2001) 1.32
Selective cancer cell killing by alpha-tocopheryl succinate. Br J Cancer (2001) 1.32
Mitochondriotoxic compounds for cancer therapy. Oncogene (2006) 1.31
Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene (1999) 1.26
The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomembr (2000) 1.25
The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol Biol Cell (2003) 1.22
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene (2001) 1.22
Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett (2006) 1.16
Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet (2000) 1.15
Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res (2005) 1.15
Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc) (2003) 1.14
Mitochondrial thioredoxin system: effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis. J Biol Chem (2004) 1.12
Distinct domains control the addressing and the insertion of Bax into mitochondria. J Biol Chem (2004) 1.11
Mitochondrial hexokinases: guardians of the mitochondria. Cell Cycle (2005) 1.10
RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res (2003) 1.08
Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. Biochim Biophys Acta (2004) 1.06
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. Cancer Cell (2003) 1.03
alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function. J Biol Chem (2006) 1.03
Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry (2003) 1.02
Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. Int J Cancer (2004) 0.99
Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate. Mol Nutr Food Res (2006) 0.98
Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress. J Biol Chem (2005) 0.93
Defective gene expression of MnSOD in cancer cells. Mol Aspects Med (1993) 0.93
Effect of alpha-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. Free Radic Biol Med (1997) 0.91
Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage. Biochemistry (2001) 0.90
Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis. FEBS Lett (2006) 0.90
Vitamin E analogues as inducers of apoptosis: structure-function relation. Br J Cancer (2003) 0.89
Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent. Curr Med Res Opin (2005) 0.89
A Chinese hamster mutant cell line with a defect in the integral membrane protein CII-3 of complex II of the mitochondrial electron transport chain. J Biol Chem (1995) 0.88
Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system? J Neurochem (2005) 0.83
High cytotoxicity of alpha-tocopheryl hemisuccinate to cancer cells is due to failure of their antioxidative defense systems. Cancer Lett (2002) 0.82
Role of thioredoxin-1 in apoptosis induction by alpha-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells. FEBS Lett (2006) 0.82
Superoxide is responsible for apoptosis in rat vascular smooth muscle cells induced by alpha-tocopheryl hemisuccinate. Biochim Biophys Acta (2001) 0.80
Vitamin E amides, a new class of vitamin E analogues with enhanced proapoptotic activity. Int J Cancer (2005) 0.77
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
HIV infection and bone mineral density in middle-aged women. Clin Infect Dis (2006) 2.67
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem (2009) 1.85
Familial and cultural perceptions and beliefs of oral hygiene and dietary practices among ethnically and socio-economicall diverse groups. Community Dent Health (2004) 1.78
Obesity and dental caries in children: a systematic review and meta-analysis. Community Dent Oral Epidemiol (2012) 1.71
Oral health-related quality of life for 8-10-year-old children: an assessment of a new measure. Community Dent Oral Epidemiol (2005) 1.60
Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun (2007) 1.57
Empirical evidence of the relationship between parental and child dental fear: a structured review and meta-analysis. Int J Paediatr Dent (2010) 1.49
Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial. Menopause (2008) 1.47
Reliability and validity of a faces version of the Modified Child Dental Anxiety Scale. Int J Paediatr Dent (2007) 1.37
Reforming NHS dentistry. BMJ (2008) 1.35
International comparisons of health inequalities in childhood dental caries. Community Dent Health (2004) 1.34
Psychological stress in undergraduate dental students: baseline results from seven European dental schools. Eur J Dent Educ (2002) 1.34
Recognizing and reporting child physical abuse: a survey of primary healthcare professionals. J Adv Nurs (2006) 1.33
Sialic acid dependence in rotavirus host cell invasion. Nat Chem Biol (2008) 1.31
Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J Biol Chem (2002) 1.26
MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res (2012) 1.21
Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2005) 1.20
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis (2013) 1.19
Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett (2006) 1.16
Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II. J Biol Chem (2010) 1.16
The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther (2007) 1.13
Sleep Complaints of Postmenopausal Women. Clin J Womens Health (2001) 1.13
PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Cell (2012) 1.11
Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent. Mol Pharmacol (2007) 1.11
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev (2012) 1.10
Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion (2012) 1.10
Developing explanatory models of health inequalities in childhood dental caries. Community Dent Health (2004) 1.10
Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res (2009) 1.09
Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City. Ethn Dis (2004) 1.08
Mitochondrially targeted anti-cancer agents. Mitochondrion (2010) 1.08
Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase. Nat Commun (2010) 1.08
Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. Mol Aspects Med (2007) 1.07
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett (2010) 1.04
Anticancer drugs targeting the mitochondrial electron transport chain. Antioxid Redox Signal (2011) 1.04
Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res (2007) 1.04
UK population norms for the modified dental anxiety scale with percentile calculator: adult dental health survey 2009 results. BMC Oral Health (2013) 1.00
A systematic review and meta-analysis of face-to-face communication of tailored health messages: implications for practice. Patient Educ Couns (2011) 0.99
Remembering and repeating childhood dental treatment experiences: parents, their children, and barriers to dental care. Int J Paediatr Dent (2009) 0.99
Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr (2009) 0.98
Some psychometric properties of the Chinese version of the Modified Dental Anxiety Scale with cross validation. Health Qual Life Outcomes (2008) 0.96
CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP. Biochem Biophys Res Commun (2008) 0.95
Elevated levels of Factor XI are associated with cardiovascular disease in women. Thromb Res (2002) 0.92
Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner. Cancer Res (2011) 0.92
A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression. Cancer Res (2007) 0.92
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis (2011) 0.91
Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence. Clin Exp Metastasis (2012) 0.91
Reactive oxygen species are generated by the respiratory complex II--evidence for lack of contribution of the reverse electron flow in complex I. FEBS J (2013) 0.91
Mitochondria transmit apoptosis signalling in cardiomyocyte-like cells and isolated hearts exposed to experimental ischemia-reperfusion injury. Redox Rep (2007) 0.90
NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi. Glycobiology (2004) 0.90
Novel structural insights into rotavirus recognition of ganglioside glycan receptors. J Mol Biol (2011) 0.89
Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy. Free Radic Biol Med (2011) 0.88
Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.88
Complexity in influenza virus targeted drug design: interaction with human sialidases. J Med Chem (2010) 0.87
Evaluating a single dental anxiety question in Finnish adults. Acta Odontol Scand (2007) 0.87
Targeting the mitochondrial electron transport chain complexes for the induction of apoptosis and cancer treatment. Curr Pharm Biotechnol (2013) 0.87
MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function. Antioxid Redox Signal (2014) 0.86
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. Maturitas (2011) 0.85
Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells. Immunol Cell Biol (2003) 0.84
ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma. Exp Hematol Oncol (2013) 0.84
Decayed and missing teeth and oral-health-related factors: predicting depression in homeless people. J Psychosom Res (2011) 0.84
K-Ras and mitochondria: dangerous liaisons. Cell Res (2011) 0.84
The relationship between dental anxiety and dental decay experience in antenatal mothers. Eur J Oral Sci (2010) 0.84
The effect of laser irradiation on proliferation of human breast carcinoma, melanoma, and immortalized mammary epithelial cells. Photomed Laser Surg (2010) 0.84
A secondary sialic acid binding site on influenza virus neuraminidase: fact or fiction? Angew Chem Int Ed Engl (2012) 0.83
Critical health promotion and education--a new research challenge. Health Educ Res (2004) 0.83
Peripheral blood MDSCs, IL-10 and IL-12 in children with asthma and their importance in asthma development. PLoS One (2013) 0.83
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83
Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus. Glycoconj J (2006) 0.83
Inhibitory effects associated with use of modified Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter assays and implications for analysis of ISGs. J Interferon Cytokine Res (2005) 0.83
Mitochondrially targeted α-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing. Antioxid Redox Signal (2011) 0.82
Exceptional longevity is associated with decreased reproduction. Aging (Albany NY) (2011) 0.82
Recognition of the GM3 ganglioside glycan by Rhesus rotavirus particles. Angew Chem Int Ed Engl (2011) 0.82
Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse. Menopause (2011) 0.82